Showing results (171-180 of 570) with videos related to

Sort By:
Pageof 57
Physiological Reviews|September 19, 2024
The liver as a central "hub" of the immune system: pathophysiological implicationsVincenzo Ronca, Alessio Gerussi, Paul Collins, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 16, 2021
The application of artificial intelligence in hepatology: A systematic reviewClara Balsano, Anna Alisi, Maurizia R Brunetto, et al.
Annali Italiani Di Chirurgia|September 26, 2022
Comparison between AIR, Alvarado and RIPASA scores in the diagnosis of acute appendicitis in a Western population. A retrospective cohort studyGaetano Poillucci, Mauro Podda, Dario Oricchio, et al.
Updates in Surgery|March 14, 2023
Nationwide analysis of inpatient laparoscopic ventral hernia repair in Italy from 2015 to 2020Emanuele Botteri, Monica Ortenzi, Sophie Williams, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 15, 2019
The application of indocyanine green-fluorescence imaging during robotic-assisted liver resection for malignant tumors: a single-arm feasibility cohort studyMarco Vito Marino, Mauro Podda, Carmen C Fernandez, et al.
World Journal of Surgery|June 22, 2019
The Application of Indocyanine Green Fluorescence Imaging During Robotic Liver Resection: A Case-Matched StudyMarco Vito Marino, Salomone Di Saverio, Mauro Podda, et al.
World Journal of Surgery|July 9, 2022
Evolving Trends in the Management of Acute Appendicitis During COVID-19 Waves: The ACIE Appy II StudyFrancesco Pata, Marcello Di Martino, Mauro Podda, et al.
Minerva Gastroenterology|December 10, 2020
Risk stratification in primary sclerosing cholangitisGiacomo Mulinacci, Laura Cristoferi, Andrea Palermo, et al.
Autoimmunity Reviews|July 10, 2016
Novel therapeutics for primary biliary cholangitis: Toward a disease-stage-based approachHani S Mousa, Marco Carbone, Federica Malinverno, et al.
Expert Opinion on Therapeutic Targets|January 18, 2022
An update on novel pharmacological agents for primary sclerosing cholangitisCamilla Gallo, Bright Oworae Howardson, Laura Cristoferi, et al.
Pageof 57